PCSK9 and fatty liver disease: In summary, this study suggests that FAF2 knockdown may alleviate alcohol-induced liver steatosis through 2 primary mechanisms: (1) modulation of SREBP1 and its downstream targets, including PCSK9, and (2) enhancement of ATGL-mediated lipolysis.